BELLUS Health (TSE:BLU) Shares Cross Below 50 Day Moving Average of $19.48

BELLUS Health Inc. (TSE:BLUGet Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$19.48 and traded as low as C$19.24. BELLUS Health shares last traded at C$19.48, with a volume of 28,666 shares traded.

BELLUS Health Price Performance

The company has a debt-to-equity ratio of 0.32, a quick ratio of 16.40 and a current ratio of 33.42. The company’s 50 day moving average price is C$19.48. The company has a market cap of C$2.47 billion, a price-to-earnings ratio of -20.29 and a beta of -0.28.

BELLUS Health Company Profile

(Get Free Report)

BELLUS Health Inc, a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus.

Featured Articles

Receive News & Ratings for BELLUS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health and related companies with MarketBeat.com's FREE daily email newsletter.